Clinical Report: Bilateral Renal Metastases After Radical Prostatectomy
Overview
This report details the case of an 81-year-old man with advanced prostate cancer who developed bilateral renal metastases five years post-radical prostatectomy. The patient's treatment regimen was adjusted, leading to significant improvement in symptoms.
Background
Prostate cancer is a prevalent malignancy in men, with visceral metastases occurring in approximately 10-15% of advanced cases. The emergence of novel endocrine therapies has improved survival rates but has also led to atypical metastatic patterns, necessitating a reevaluation of management strategies. Understanding these patterns is crucial for optimizing treatment in patients with advanced disease.
Data Highlights
No numerical data or trial data is presented in the article.
Key Findings
The patient presented with hematuria and a total PSA level of 274.71 ng/mL.
A biopsy confirmed metastatic prostate acinar adenocarcinoma with high Ki67 proliferative activity (40%).
Endocrine therapy was changed to rezvilutamide combined with degarelix, resulting in significant symptom improvement.
This case contributes to the limited literature on visceral metastases in castration-sensitive prostate cancer.
Clinical Implications
Rigorous postoperative surveillance is essential for early detection of metastases in prostate cancer patients. Timely adjustments to endocrine therapy regimens can lead to improved patient outcomes in cases of advanced metastatic disease.
Conclusion
This case underscores the importance of personalized treatment strategies in managing atypical metastatic patterns in prostate cancer. Further research is needed to explore optimal treatment approaches for advanced metastatic disease.
